Alkaline Phosphatase as a Potential Biomarker of Muscle Function: A Pilot Study in Patients with Hypophosphatasia
Authors:
- María Carmen Andreo-LópezMAMaría Carmen Andreo-López
- Victoria Contreras-BolívarVCVictoria Contreras-Bolívar
- Luis Martínez-HerediaLMLuis Martínez-Heredia
- Francisco Andújar-VeraFAFrancisco Andújar-Vera
- Diego Becerra-GarcíaDBDiego Becerra-García
- Trinidad González-CejudoTGTrinidad González-Cejudo
- Sheila González-SalvatierraSGSheila González-Salvatierra
- Cristina García-FontanaCGCristina García-Fontana
- Beatriz García-FontanaBeatriz García-Fontana
- Manuel Muñoz-TorresMMManuel Muñoz-Torres
Open Access
- 26 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6153
Abstract
Alkaline phosphatase (ALP) deficiency has been linked to reduced physical performance, as seen in hypophosphatasia (HPP). However, its potential role in muscle function has not been fully explored. This was a cross-sectional study in 34 HPP adults and 34 matched healthy controls. Muscle strength was assessed using handgrip strength (HGS), considering values below the 10th percentile of the Spanish population as low strength. Muscle mass was evaluated using dual-energy X-ray absorptiometry and morphometric ultrasound. Bone mineral density (BMD) was measured at the lumbar spine, femoral neck, and total hip. The prevalence of low muscle strength was significantly higher in the HPP group compared to controls (30% vs. 6%; p = 0.009), with decreased HGS in the HPP group (p = 0.039). Positive associations were observed between ALP and femoral neck BMD, leg circumference, and fat-free mass and an inverse association with tricipital skinfold. Subjects with serum ALP activity below the sex-adjusted median had a significantly higher risk of low muscle strength independently of HPP diagnosis. ALP remained independently associated with HGS (p = 0.005), and a predictive model using ALP values showed strong capability to predict low-muscle-strength risk. Based on these results, we conclude circulating ALP levels are independently associated with muscle strength and may represent a useful biomarker for the early detection of muscle dysfunction. Future longitudinal or interventional studies are needed to assess whether ALP plays a causal role in muscle strength.Keywords
Funding Information
- Instituto de Salud Carlos III (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
- Junta de Andalucía (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
- Instituto de Salud Carlos III (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
- Instituto de Salud Carlos III (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
- Junta de Andalucía (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
- Junta de Andalucía (PI21/01069, EXC-2023-06, CB16/10/00475, CM23/00064, CD24/00003, B-0019-2023, F2-0037-2022, C1-S0033, CP22/00022)
This publication has 35 references indexed in Scilit:
- Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populationsBone Reports, 2022
- Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional studyOsteoporosis International, 2022
- Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasiaBone, 2021
- Hypophosphatasia: an overview of the disease and its treatmentOsteoporosis International, 2015
- Diagnostic criteria for malnutrition – An ESPEN Consensus StatementClinical Nutrition, 2015
- Clinical Aspects of Hypophosphatasia: An UpdateClinical & Translational Metabolism, 2013
- HypophosphatasiaBest Practice & Research Clinical Rheumatology, 2008
- Study of bone mineral density in lumbar spine and femoral neck in a Spanish populationOsteoporosis International, 1997
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994
- The human alkaline phosphatases: What we know and what we don't knowClinica Chimica Acta, 1990